Department of Obstetrics and Gynecology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.
Department of Obstetrics and Gynecology, Umeå University Hospital, Umeå, Sweden.
Acta Obstet Gynecol Scand. 2020 Sep;99(9):1230-1237. doi: 10.1111/aogs.13843. Epub 2020 Apr 15.
Smoking cessation, both pre- and postoperatively, is important to reduce complications associated with surgery. Identifying feasible and effective means of alerting the patient before surgery to the importance of perioperative smoking cessation is a challenge to healthcare systems.
A randomized registry-based trial using the web-version of the Swedish national quality register for gynecological surgery, GynOp, was performed (ClinicalTrials.gov NCT03942146). Current smokers scheduled for gynecological surgery were randomly assigned before surgery to group 1 (control group, no specific information), group 2 (web-based written information), group 3 (information to doctor that the woman was a smoker and should be recommended smoking cessation or group 4 (a combination of groups 2 and 3). Perioperative smoking habits were evaluated in a postoperative questionnaire 2 months after surgery. The treatment effect was estimated to be a 15% reduction in the number of smokers at the time of surgery. Thus, 94 women in each group were required, in total 376 women, using a one-sided test with an alpha level of 0.001 and a statistical power of 80%.
Participants (n = 1427) were recruited between 5 November 2015 and 6 December 2017. A total of 1137 smokers responded to the follow-up questionnaire (80%), with 486 women declining to participate, leaving 651 women eligible for analysis. Women who received both web-based information prior to surgery and information from a doctor, reported smoking cessation more often from 1 to 3 weeks preoperatively (Odds ratio [OR] 1.8, 95% confidence interval [CI] 1.0-3.3) and 1 to 3 weeks after surgery (OR 1.9, 95% CI 1.1-3.3) compared with the control group who received no specific information.
A combination of written information in the health declaration and a recommendation from a doctor regarding smoking cessation may be associated with higher odds of smoking cessation at 1-3 weeks pre- and postoperatively.
术前和术后戒烟对于减少手术相关并发症非常重要。确定在手术前通过切实可行且有效的方式提醒患者围手术期戒烟的重要性,是医疗体系面临的一项挑战。
我们开展了一项基于随机登记的试验,使用瑞典妇科手术国家质量登记处 GynOp 的网络版(ClinicalTrials.gov NCT03942146)。计划接受妇科手术的当前吸烟者在术前被随机分配到以下 4 组:第 1 组(对照组,无特定信息)、第 2 组(基于网络的书面信息)、第 3 组(通知医生该女性是吸烟者且应建议其戒烟)和第 4 组(组 2 和组 3 的组合)。术后 2 个月通过术后问卷调查评估围手术期吸烟习惯。预计治疗效果为手术时吸烟人数减少 15%。因此,每组需要 94 名女性,总计 376 名女性,单侧检验的 α 值为 0.001,统计效能为 80%。
2015 年 11 月 5 日至 2017 年 12 月 6 日期间共招募了 1427 名参与者。共有 1137 名吸烟者对随访问卷做出了回应(80%),486 名女性拒绝参与,651 名女性符合分析条件。与未接受任何特定信息的对照组相比,在术前 1-3 周和术后 1-3 周,同时接受术前网络信息和医生建议的女性报告的戒烟率更高(比值比 [OR] 1.8,95%置信区间 [CI] 1.0-3.3)。
健康申报中的书面信息与医生关于戒烟的建议相结合,可能与术前和术后 1-3 周内更高的戒烟几率相关。